联环药业：获得《药物临床试验批准通知书》

每日经济新闻11-05

每经AI快讯，联环药业（SH 600513，收盘价：9.77元）11月5日晚间发布公告称，江苏联环药业股份有限公司于近日收到国家药品监督管理局核准签发的关于利多卡因丙胺卡因气雾剂的《药物临床试验批准通知书》，并将于近期开展临床试验。2023年1至12月份，联环药业的营业收入构成为：医药流通占比57.33%，医药制造占比41.68%。联环药业的董事长是钱振华，男，53岁，学历背景为大专；总经理是牛犇...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2481088522?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-05 17:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2481088522","market":"sh","top_or_hot":-1,"title":"联环药业：获得《药物临床试验批准通知书》","media":"每日经济新闻","content":"<div>\n<p>每经AI快讯，联环药业（SH 600513，收盘价：9.77元）11月5日晚间发布公告称，江苏联环药业股份有限公司于近日收到国家药品监督管理局核准签发的关于利多卡因丙胺卡因气雾剂的《药物临床试验批准通知书》，并将于近期开展临床试验。2023年1至12月份，联环药业的营业收入构成为：医药流通占比57.33%，医药制造占比41.68%。联环药业的董事长是钱振华，男，53岁，学历背景为大专；总经理是牛犇...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105173627a218172d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>联环药业：获得《药物临床试验批准通知书》</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n联环药业：获得《药物临床试验批准通知书》\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-05 17:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105173627a218172d&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>每经AI快讯，联环药业（SH 600513，收盘价：9.77元）11月5日晚间发布公告称，江苏联环药业股份有限公司于近日收到国家药品监督管理局核准签发的关于利多卡因丙胺卡因气雾剂的《药物临床试验批准通知书》，并将于近期开展临床试验。2023年1至12月份，联环药业的营业收入构成为：医药流通占比57.33%，医药制造占比41.68%。联环药业的董事长是钱振华，男，53岁，学历背景为大专；总经理是牛犇...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105173627a218172d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105173627a218172d&s=b","article_id":"2481088522","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105173627a218172d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2481088522","pubTimestamp":1730799326,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"每经AI快讯，联环药业 11月5日晚间发布公告称，江苏联环药业股份有限公司于近日收到国家药品监督管理局核准签发的关于利多卡因丙胺卡因气雾剂的《药物临床试验批准通知书》，并将于近期开展临床试验。2023年1至12月份，联环药业的营业收入构成为：医药流通占比57.33%，医药制造占比41.68%。联环药业的董事长是钱振华，男，53岁，学历背景为大专；总经理是牛犇，男，43岁，学历背景为博士。截至发稿，联环药业市值为28亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600513":"联环药业","BK0239":"医药制造"},"translate_title":"Lianhuan Pharmaceutical: Obtained the \"Notice of Drug Clinical Trial Approval\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600513":1},"content_text":"每经AI快讯，联环药业（SH 600513，收盘价：9.77元）11月5日晚间发布公告称，江苏联环药业股份有限公司于近日收到国家药品监督管理局核准签发的关于利多卡因丙胺卡因气雾剂的《药物临床试验批准通知书》，并将于近期开展临床试验。2023年1至12月份，联环药业的营业收入构成为：医药流通占比57.33%，医药制造占比41.68%。联环药业的董事长是钱振华，男，53岁，学历背景为大专；总经理是牛犇，男，43岁，学历背景为博士。截至发稿，联环药业市值为28亿元。道达号（daoda1997）“个股趋势”提醒：1. 近30日内无机构对联环药业进行调研。每经头条（nbdtoutiao）——创造历史！中国上市公司回购金额首超股权融资，资本市场吸引力大增（附407家实力公司）(记者 王晓波)","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481088522"}